Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06805266 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06805266 · ClinicalTrials.gov record · last posted 2025-02-06

Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease

StatusNot Yet Recruiting
PhasePhase 4
Started2025-02
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The present study involves patients with Parkinson Disease (PD) suffering from freezing of gait (FOG) and depressive symptoms. The main aim of the study is evaluating the efficacy of vortioxetine in reducing moderate/severe FOG not responsive to dopaminergic treatment in patients with PD with depressive symptoms.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2025-01-29. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06805266
Lead Sponsor Marianna Amboni
Conditions Parkinson Disease, Idiopathic, Freezing of Gait, Depression Not Otherwise Specified
Enrollment 40 participants
Start Date 2025-02
Primary Completion 2026-12 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-02-06